Recurrence is a serious complication of acute pericarditis. Recurrent pericarditis is a term used when a pericarditis patient relapses after discontinuation of treatment. It can also be described as a ...

Rilonacept treatment resulted in a 96% reduction in risk of recurrent pericarditis events (primary efficacy endpoint: Hazard Ratio = 0.04, p<0.0001) Safety results consistent with FDA-approved label ...

August 28, 2011 (Paris, France) — Italian researchers have shown that colchicine, when given in addition to conventional therapy, prevents recurrent episodes of pericarditis [1]. "Colchicine appears ...

Advances in imaging techniques and new treatments are changing the management of recurrent pericarditis, improving outcomes for patients with formerly treatment-resistant disease, researchers reported ...

HealthDay News — Use of anakinra reduces the risk of recurrence of pericarditis among patients with recurrent pericarditis with colchicine resistance and corticosteroid dependence, according to a ...

The American College of Cardiology (ACC) reported January 4, 2023, that new research on treatment of recurrent pericarditis involving cardiac magnetic resonance imaging and interlukin-1 inhibitors may ...

Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago. Based on a successful ...

HAMILTON, Bermuda, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline of assets designed to modulate immunological ...

- ARCALYST is the first and only FDA-approved therapy for recurrent pericarditis -- Commercial launch expected in April 2021 -- Kiniksa launches Kiniksa One Connect™ patient support program -- ...

HAMILTON, Bermuda, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and ...

Credit: Getty Images A discussion on the new American Heart Association’s pericarditis initiative with Jimmy Kerrigan, MD. For the estimated 40,000 adults with recurrent pericarditis in the United ...

Recurrent pericarditis occurred in one fifth of patients with systemic lupus erythematosus (SLE), with higher recurrence rates observed in younger patients and those receiving oral prednisone therapy.